Buscar resultados de ensayos clínicos
Carbohydrate Metabolism, Inborn Errors - 25 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Phase II Open Label Study Using Triheptanoin in Patients With Glucose Type 1 Transporter Deficiency GLUT1-DS Condición: Glut1 Deficiency Syndrome Fecha: 2013-12-03 Intervenciones: Drug: GLUT1 DS |
Completed |
Nombre del estudio: Congenital Sucrase-Isomaltase Deficiency (CSID) Genetic Prevalence Study (GPS) Condición: Congenital Sucrase-isomaltase Deficiency (CSID) Fecha: 2013-07-22 |
Completed |
Nombre del estudio: Carbohydrate Intolerance Questionnaire Study Condición: Carbohydrate Intolerance Fecha: 2017-04-25 Intervenciones: Dietary Supplement: TRUTOL Glucose Tolerance Beverage A caffeine-free, non-carbonated, glucose tolerance |
Completed |
Nombre del estudio: Measuring the Glycemic Index of Pulse Based Breads Condición: Carbohydrate Intolerance Fecha: 2017-01-06 Intervenciones: Other: Bread |
Active, not recruiting |
Nombre del estudio: A Trial to Evaluate the Frequency of Genetic Sucrase-Isomaltase Deficiency Genotypes, and the Efficacy and Safety of Sucraid® (Sacrosidase) Oral Solution in Subjects With Chronic Diarrhea and Sucrase Deficiency Condición: Genetic Sucrase-Isomaltase Deficiency Fecha: 2016-05-18 Intervenciones:
|
Enrolling by invitation |
Nombre del estudio: Study to Assess the Long Term Safety and Efficacy of UX007 in Subjects With Glucose Type 1 DS Condición: Glucose Transporter Type 1 Deficiency Syndrome Fecha: 2015-11-03 Intervenciones: Drug: UX007 UX007 is a liquid intended for oral (PO) administration. |
Recruiting |
Nombre del estudio: An Open-Label Trial of Triheptanoin in Patients With Glucose Transporter Type-1 Deficiency Syndrome Condición: Glucose Transporter Type-1 Deficiency Syndrome (Glut1 DS) Fecha: 2014-01-13 Intervenciones: Drug: Triheptanoin Schedule A: Subjects previously treated |
Not yet recruiting |
Nombre del estudio: Triheptanoin (C7 Oil), a Food Supplement, for Glucose Transporter Type I Deficiency (G1D) Condición:
Fecha: 2013-12-12 Intervenciones: Drug: Triheptanoin Triheptanoin (C7 oil) is a 7-carbon medium chain triglyceride. |
Not yet recruiting |
Nombre del estudio: Treatment Development for Glucose Transporter Type I Deficiency Syndrome (G1D) Condición:
Fecha: 2013-12-11 Intervenciones: Drug: Triheptanoin Triheptanoin is a 7-carbon medium chain triglyceride |
Available |
Nombre del estudio: Post Study Continuation of C7 for G1D Condición:
Fecha: 2013-12-11 Intervenciones: Drug: Triheptanoin Other Names:
|